戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 predominantly in the distal renal pelvis and ureteropelvic junction.
2 h a single ureteral stone not located at the ureteropelvic junction.
3 ral calculi, excluding the ureterovesical or ureteropelvic junctions.
4  induced by SCFA-induced inflammation in the ureteropelvic junction and proximal ureter.
5 vessels, wider caliber reconstruction of the ureteropelvic junction, and full-thickness healing with
6  signaling in smooth muscle formation at the ureteropelvic junction, and the predominant contribution
7 of the kidney, ureteral bud differentiation, ureteropelvic junction formation, and bladder and trigon
8 U cases, which consisted of individuals with ureteropelvic junction obstruction ( n =321), ureteroves
9            Controversies in the diagnosis of ureteropelvic junction obstruction and in the surgical r
10 gement of ureteral pathology, in particular, ureteropelvic junction obstruction and ureteric strictur
11    The most common underlying conditions are ureteropelvic junction obstruction and vesicoureteral re
12 stone size and associated conditions such as ureteropelvic junction obstruction are factors that may
13 lly invasive procedures for the treatment of ureteropelvic junction obstruction available, the treatm
14 nital obstructive nephropathy that resembles ureteropelvic junction obstruction in humans.
15                          Robotic surgery for ureteropelvic junction obstruction is an evolving techni
16                                    Intrinsic ureteropelvic junction obstruction is the most common ca
17 truction available, the treatment choice for ureteropelvic junction obstruction must be based on seve
18 To review factors that affect the success of ureteropelvic junction obstruction repair and recent dev
19 cted from children with congenital intrinsic ureteropelvic junction obstruction revealed a molecular
20 cts are observed frequently in patients with ureteropelvic junction obstruction, a common form of hyd
21        There were three patients treated for ureteropelvic junction obstruction, one with balloon dil
22 en a crossing vessel is the primary cause of ureteropelvic junction obstruction, poor renal function
23  each of renal cell carcinoma, appendicitis, ureteropelvic junction obstruction, renal subcapsular he
24 role of robotic systems in the management of ureteropelvic junction obstruction, rigorous prospective
25  hemangiomas or arteriovenous malformations, ureteropelvic junction obstruction, ureteral strictures,
26 stem in pediatric urology is pyeloplasty for ureteropelvic junction obstruction.
27 for ureterovesical anastomotic strictures or ureteropelvic junction obstruction.
28 ent mechanism underlying mammalian intrinsic ureteropelvic junction obstruction.
29  established management approach for primary ureteropelvic junction obstruction.
30 s have emerged recently for the treatment of ureteropelvic junction obstruction.
31 d during the genesis of congenital intrinsic ureteropelvic junction obstruction.
32 e of these had a clinical diagnosis of right ureteropelvic junction obstruction.
33 imally invasive procedures for the repair of ureteropelvic junction obstruction.
34 omal-dominant form of CAKUT with predominant ureteropelvic junction obstruction.
35                           Obstruction of the ureteropelvic junction (UPJ) is a common congenital anom
36                                          The ureteropelvic junction (UPJ) region, where the renal pel
37 ogy, numerous markers for renal obstruction [ureteropelvic junction (UPJ)] and vesicoureteral reflux
38                       Tissue obstructing the ureteropelvic junction was marked as early as E13.5 by a
39 ng indicated that stromal cells blocking the ureteropelvic junction were derived from intermediate me